USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:36 PM 2012

NYSE 8092.11 9.13 Index Moved Up

NASDAQ 2929.72 13.86 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and NUTR...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

Nutraceutical International Co

Volatility

Matrix

Run Correlation

Diversification

Good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Nutraceutical International Co in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.19

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	92.0%
Values	Daily Returns

Suggest

48.91

Intraday

One Month

^(0.31)

0.63%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	P/B Ratio	6.06
Open	49.47	Day Low	48.80
Market Cap	2.892B	Volume	149720
Last Close	49.22	Short Ratio	7.80
Last Traded	2/9/2012	Year High	50.28
Percent Change	0.63%	EBITDA	142.7M
Year Low	25.64	Absolute Change	0.31
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Day High	49.8084
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

Illumina's Board Unanimously Rejects Roche's Offer; Shire Announces FDA ...

BioMedReports (subscription) - Feb 8, 2012

By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 7, 2012.

2012-02-07

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation ...

MarketWatch (press release) - Feb 7, 2012

RALEIGH, NC, Feb 07, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. /quotes/zigman/87125/quotes/nls/slxp SLXP -0.25% today announced that the US Food and Drug Administration (FDA) has granted Priority Review designation for the Company's New Drug ...

Salix Pharmaceuticals Announces FDA Priority Review Designation for Crofelemer NDA
- NCTechNews (press release)

2012-02-07

Salix Pharmaceuticals Announces FDA Granting Of Priority Review Designation For Crofelemer NDA For Treatment Of Diarrhea

Reuters Key Development - Feb 7, 2012

2012-02-07

Salix Pharmaceuticals Crosses Above its 10-day MA (SLXP)

Financial News Network Online - Jan 31, 2012

Salix Pharmaceuticals (NASDAQ:SLXP) shares have crossed bullishly above their 10-day moving average of $46.89 on a volume of 132K shares.

2012-01-31

Salix Scores with Oral Relistor

2011-12-27

Salix Pharmaceuticals (SLXP): Zacks Rank Buy

2011-12-19

Zacks Bull and Bear of the Day Highlights: Salix Pharmaceuticals, Montpelier Re Holdings, Wal-Mart, Macy's and Best Buy

2011-11-28

14.19

Intraday

One Month

^(0.02)

0.14%

NUTR

NASDAQ

Nutraceutical International Co

P/E	9.66	P/B Ratio	1.17
Open	14.24	Day Low	14.12
Market Cap	141.1M	Volume	9900
Last Close	14.21	Short Ratio	10.70
Last Traded	2/9/2012	Year High	15.99
Percent Change	0.14%	EBITDA	32.8M
Year Low	10.65	Absolute Change	0.02
Book Value	12.195	EPS	1.471
Day High	14.37	Target Price	17.00
Current EPS	1.471	This Year EPS	1.72
Next Year EPS	1.77	Current PE	9.66
This Year PE	8.26	Next Year PE	8.03

WILC, NUTR & THER: Are These Small Cap Stocks About to Break the Trendline ...

SmallCap Network - Feb 1, 2012

WILC, NUTR & THER: Are These Small Cap Stocks About to Break the Trendline Resistance Barrier? A closer look at the fundamentals of small cap stocks G. Willi-Food International Limited (WILC), Nutraceutical Int'l Corp.

2012-02-01

Reported Lower EPS Than Expected: LYTS, NUTR, LOGI, CRR, POT, BLL, DEST

TomRollins.com - Jan 26, 2012

LSI Industries, Inc. (Public, NASDAQ:LYTS). Last Market Price: $6.55, Change -0.48, % Change (-6.83%). Shares trade in the range of $6.41 - $6.72 dollars.

2012-01-26

NUTRACEUTICAL INT'L CORP. : Nutraceutical Reports Fiscal 2012 Q1 Results

4-traders (press release) - Jan 26, 2012

PARK CITY, Utah, Jan. 26, 2012 /PRNewswire/ -- Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2012 first quarter ended December 31, 2011.

2012-01-26

Nutraceutical International Corporation Increases Credit Line

Reuters Key Development - Dec 21, 2010

2010-12-21